Thu. 29 Feb 2024, 2:24pm ET
Benzinga
Biotech, News, General
LAVA Therapeutics N.V Filed U.S. Patent Application #20240067726-A1 For "Single Domain Antibodies Targeting CD1D"
Company Profile